About the authors
Султаналиева Роза Бакаевна, д.м.н., профессор кафедры терапии Кыргызско-Российского Славянского университета, Бишкек, Кыргызская Республика
Рысбекова Гульнара Сатаровна, к.м.н., cтарший преподаватель Ошского государственного университета, Ош, Кыргызская Республика
Абылова Назгуль Кубанычбековна, ассистент и аспирант профессорского курса эндокринологии КГМИПиПК им. С.Б. Даниярова, врач-эндокринолог Эндокринологического центра Министерства здравоохранения Кыргызской Республики, Бишкек, Кыргызская Республика
Мурзакаримова Лариса Кочкарбаевна, Врач статистик Центра электронного здравоохранения при Министерстве здравоохранения, Бишкек, Кыргызская Республика
Sultanalieva Roza Bakaevna, MD, Professor, Department of Therapy, Kyrgyz-Russian Slavic University, Bishkek, Kyrgyz Republic
Rysbekova Gulnara Satarovna, Ph.D., Senior Lecturer, Osh State University, Osh, Kyrgyz Republic
Abylova Nazgul Kubanychbekovna, assistant and postgraduate student of the professorial course of endocrinology, KSMIRaAT named after S.B. Daniyarov, Endocrinologist, Endocrinological Center of the Ministry of Health of the Kyrgyz Republic, Bishkek, Kyrgyz Republic
Murzakarimova Larisa Kochkarbaevna, Statistician, Center for eHealth under the Ministry of Health, Bishkek, Kyrgyz Republic
Султаналиева Роза Бакаевна, м.и.д.,терапия кафедрасынын профессору, Б. Н. Ельцин атындагы Кыргыз-Россия Славян университетинин, Бишкек, Кыргыз Республикасы
Рысбекова Гульнара Сатаровна, м.и.к., улук окутуучу, Ош мамлекеттик университетинин, Ош, Кыргыз Республикасы
Абылова Назгүл Кубанычбековна, ассистент жана аспирант эндокринологиянын профессоранын курсунун С. Б. Данияров атындагы Кыргыз Мамлекеттик кайрадан даярдоо жана квалификацияны жогорулатуу медициналык институтунун; Кыргыз Республикасынын Саламаттык сактоо министрлигинин Эндокринологиялык борборунун эндокринологу, Бишкек, Кыргыз Республикасы
Мурзакаримова Лариса Кочкарбаевна, Саламаттык сактоо министрлигине караштуу Электрондук саламаттыкты сактоо борбордун статисти, Бишкек, Кыргыз Республикасы
References
1. Global report on diabetes 2016/ World Health Organization; 2016.
2. IDF Diabetes Atlas 2015 – 7th edition | www.diabetesatlas.org.
3. Nakamura K, Fuster J, Walsh K. Adipokines: a link between obesity and cardiovascular disease. J Cardiol 2014; 63 (4): 250-9. DOI: 10.1016/j.jjcc.2013.11.006.
4. Influence of behavioral risk factors on the prevalence and risk of developing type 2 diabetes in Kyrgyzstan (STEPS study) [Text] / R.B. Sultanaliev, / V.G. Knyazev, / Vestnik KRSU. - 2016. - Volume 16. - No. 11. -– P. 118-121.
5. Knyazeva V.G. The prevalence of type 2 diabetes mellitus, early disorders of carbohydrate metabolism and their main risk factors in the Kyrgyz Republic: Dis. ... Candidate of Medical Sciences / - Bishkek 2018. - 120 p.
6. Complications of diabetes mellitus: treatment and prevention / Ed. I.I. Dedova, M.V. Shestakova. - M .: LLC Publishing House Medical Information Agency, 2017. [Dedov II, Shestakova MV, eds. Complications of diabetes mellitus: treatment and prevention. Moscow: Meditsinskoe informatsionnoe agentstvo; 2017]. WHO (2017).
7. Prevention and control of noncommunicable diseases in Kyrgyzstan: arguments for investment / World Health Organization. -2017 - 48 p.
8. The prevalence of type 2 diabetes mellitus and its main risk factors among urban and rural residents of Kyrgyzstan [Text] /R.B. Sultanaliev, V.G. Knyazev, // Vestnik KRSU. - 2014. - Volume 14. - No. 4. - P. 150-153.
9. Sultanalieva R.B., Knyazeva V.G. Epidemiological aspects of diabetes mellitus in Kyrgyzstan / Vestnik KRSU, 2016, No. 11
1. Global report on diabetes 2016/ World Health Organization; 2016.
2. IDF Diabetes Atlas 2015 – 7th edition | www.diabetesatlas.org.
3. Nakamura K, Fuster J, Walsh K. Adipokines: a link between obesity and cardiovascular disease. J Cardiol 2014; 63 (4): 250-9. DOI: 10.1016/j.jjcc.2013.11.006.
4. Influence of behavioral risk factors on the prevalence and risk of developing type 2 diabetes in Kyrgyzstan (STEPS study) [Text] / R.B. Sultanaliev, / V.G. Knyazev, / Vestnik KRSU. - 2016. - Volume 16. - No. 11. -– P. 118-121.
5. Knyazeva V.G. The prevalence of type 2 diabetes mellitus, early disorders of carbohydrate metabolism and their main risk factors in the Kyrgyz Republic: Dis. ... Candidate of Medical Sciences / - Bishkek 2018. - 120 p.
6. Complications of diabetes mellitus: treatment and prevention / Ed. I.I. Dedova, M.V. Shestakova. - M .: LLC Publishing House Medical Information Agency, 2017. [Dedov II, Shestakova MV, eds. Complications of diabetes mellitus: treatment and prevention. Moscow: Meditsinskoe informatsionnoe agentstvo; 2017]. WHO (2017).
7. Prevention and control of noncommunicable diseases in Kyrgyzstan: arguments for investment / World Health Organization. -2017 - 48 p.
8. The prevalence of type 2 diabetes mellitus and its main risk factors among urban and rural residents of Kyrgyzstan [Text] /R.B. Sultanaliev, V.G. Knyazev, // Vestnik KRSU. - 2014. - Volume 14. - No. 4. - P. 150-153.
9. Sultanalieva R.B., Knyazeva V.G. Epidemiological aspects of diabetes mellitus in Kyrgyzstan / Vestnik KRSU, 2016, No. 11
1. Global report on diabetes 2016/ World Health Organization; 2016.
2. IDF Diabetes Atlas 2015 – 7th edition | www.diabetesatlas.org.
3. Nakamura K, Fuster J, Walsh K. Adipokines: a link between obesity and cardiovascular disease. J Cardiol 2014; 63 (4): 250-9. DOI: 10.1016/j.jjcc.2013.11.006.
4. Influence of behavioral risk factors on the prevalence and risk of developing type 2 diabetes in Kyrgyzstan (STEPS study) [Text] / R.B. Sultanaliev, / V.G. Knyazev, / Vestnik KRSU. - 2016. - Volume 16. - No. 11. -– P. 118-121.
5. Knyazeva V.G. The prevalence of type 2 diabetes mellitus, early disorders of carbohydrate metabolism and their main risk factors in the Kyrgyz Republic: Dis. ... Candidate of Medical Sciences / - Bishkek 2018. - 120 p.
6. Complications of diabetes mellitus: treatment and prevention / Ed. I.I. Dedova, M.V. Shestakova. - M .: LLC Publishing House Medical Information Agency, 2017. [Dedov II, Shestakova MV, eds. Complications of diabetes mellitus: treatment and prevention. Moscow: Meditsinskoe informatsionnoe agentstvo; 2017]. WHO (2017).
7. Prevention and control of noncommunicable diseases in Kyrgyzstan: arguments for investment / World Health Organization. -2017 - 48 p.
8. The prevalence of type 2 diabetes mellitus and its main risk factors among urban and rural residents of Kyrgyzstan [Text] /R.B. Sultanaliev, V.G. Knyazev, // Vestnik KRSU. - 2014. - Volume 14. - No. 4. - P. 150-153.
9. Sultanalieva R.B., Knyazeva V.G. Epidemiological aspects of diabetes mellitus in Kyrgyzstan / Vestnik KRSU, 2016, No. 11